George Georgiou - University of Texas at Austin Dr Georgiou is co-inventor of 29 issued and 46 pending US patents Notably, 16 different technology suites (comprising either one or multiple patents) have been licensed to majorepharmaceutical and biotechnology companies
McKetta Department of Chemical Engineering - George Georgiou Texas ChE Projects Funded by 2024 Strategic Energy Seed Grant Program The Energy Institute at the University of Texas at Austin has funded 12 research projects through its 2024 Strategic Energy Seed Grant Program, Read more …
Dr. George Georgiou – Translational Protein Therapeutics Lab His research is focused on understanding the serological antibody repertoire (as well as the BCR and TCR repertoires) in human health and disease and on the discovery and preclinical development of enzyme and antibody therapeutics for cancer and for inborn errors of metabolism
UT Experts : University Communications : The University of Texas at Austin Dr Georgiou joined the faculty at The University of Texas at Austin in 1986 He earned his doctoral degree in chemical engineering from Cornell University in 1987 He is a member of the National Academy of Engineering and the American Academy of Microbiology and has received numerous international awards
George Georgiou, Ph. D. - Dell Medical School George Georgiou, Ph D Courtesy Professor, Department of Oncology Program Leader of Developmental Therapeutics, Livestrong Cancer Institutes
George Georgiou, Ph. D. - Department of Biomedical Engineering Dr Georgiou is co-inventor of 29 issued and 46 pending US patents Notably, 16 different technology suites (comprising either one or multiple patents) have been licensed to majorepharmaceutical and biotechnology companies
George Georgiou - Department of Molecular Biosciences Georgiou's research is focused on understanding the serological antibody repertoire (as well as the BCR and TCR repertoires) in human health and disease the discovery and preclinical development of enzyme and antibody therapeutics for cancer and for inborn errors of metabolism
About – Translational Protein Therapeutics Lab - University of Texas . . . Focused on the discovery and development of protein therapeutics and on the analysis of adaptive immune responses since 2009 The discovery, early development and preclinical validation of protein therapeutics for the treatment of cancer, inborn errors of metabolism disorders and other diseases
George Georgiou - University of Texas at Austin Inventor of the Year, University of Texas at Austin, 2014 Named as one of “Top 20 Translational Researchers,” by Nature Biotechnology, 2014 Elected to National Academy of Medicine (NAM), 2011 Named as one of “100 Eminent Chemical Engineers of the Modern Era,” American Institute of Chemical Engineering (AIChE), 2008
Contact – Translational Protein Therapeutics Lab Dr George Georgiou Phone: (512) 471-6975 Fax: (512) 471-7060 E-mail: gg [at]che utexas edu Administrative Support Lizzie Miller, CRA Senior Grants Contracts Specialist Office Location: CPE Building, Room 4 414 Phone: (512) 471-9260 Fax: (512) 471-7060 E-mail: emiller [at]che utexas edu Mailing Address: Chemical Engineering UT Austin 200 E Dean Keeton Street, C0400 Austin, TX 78712-0231